Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

22 sept. 2015 16h15 HE | Source: Vaxart, Inc.

Biota Pharmaceuticals to Present at Ladenburg Thalmann 2015 Healthcare Conference

ATLANTA, Sept. 22, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals...
22 sept. 2015 07h00 HE | Source: Vaxart, Inc.

Biota Pharmaceuticals Appoints Armando Anido and Michael Dunne, M.D. to Its Board of Directors

ATLANTA, Sept. 22, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals...
11 sept. 2015 07h00 HE | Source: Vaxart, Inc.

Biota Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2015 Financial Results

ATLANTA, Sept. 11, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals...
04 sept. 2015 12h30 HE | Source: Vaxart, Inc.

Biota Pharmaceuticals to Host Conference Call to Report Fourth Quarter and Fiscal Year 2015 Financial Results on September 11, 2015

ATLANTA, Sept. 4, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals...
02 sept. 2015 08h00 HE | Source: Vaxart, Inc.

Biota Pharmaceuticals to Present at Rodman & Renshaw 17th Annual Global Investment Conference

ATLANTA, Sept. 2, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals...
20 août 2015 09h24 HE | Source: Vaxart, Inc.

Biota Advances RSV Program With Commencement of Dosing in Phase 1 Trial for Direct-Acting Antiviral BTA585

ATLANTA, Aug. 20, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) ("Biota" or the "Company"), a biopharmaceutical company focused on the discovery and development of direct-acting...
03 juin 2015 08h48 HE | Source: Vaxart, Inc.

Biota Pharmaceuticals Completes Acquisition of Anaconda Pharma

ATLANTA, June 3, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals (Nasdaq:BOTA) ("Biota" or the "Company") announced today that it has completed the acquisition of Anaconda Pharma, a privately-held...
07 mai 2015 07h00 HE | Source: Vaxart, Inc.

Biota Pharmaceuticals Reports Third Quarter Fiscal Year 2015 Financial Results

ATLANTA, May 7, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of products to prevent and...
30 avr. 2015 16h01 HE | Source: Vaxart, Inc.

Biota Pharmaceuticals to Host Conference Call to Report Third Quarter Fiscal Year 2015 Financial Results

ATLANTA, April 30, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA), a biopharmaceutical company focused on the discovery and development of products to prevent and treat serious and...
03 mars 2015 17h27 HE | Source: Vaxart, Inc.

Biota Pharmaceuticals to Present at the 27th Annual Roth Conference

ATLANTA, March 3, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of products to prevent and...

Page précédente